CSF metabolomics alterations after aneurysmal subarachnoid hemorrhage: what do we know?
Wing Mann HoFranziska A SchmidtClaudius ThoméOndra PetrPublished in: Acta neurologica Belgica (2023)
There is increasing evidence suggesting that biomarkers can give insight in the pathogenesis and can serve as an outcome predictor. In this mini review, we present a brief overview of metabolomics profiling in neuroscience and wish to discuss the predictive and therapeutic value in aSAH patients.